Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L C Contino

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Pharmacology|May 23, 1998
Involvement of nitric oxide synthase in proteinuria associated with chronic renal disease in ratsD P Brooks, L C Contino
Archives of Biochemistry and Biophysics|January 1, 1988
Rat kidney mitochondrial carbonic anhydraseS J Dodgson, L C Contino
European Journal of Pharmacology|December 29, 1995
Prevention of cyclosporine A-induced renal vasoconstriction by the endothelin receptor antagonist SB 209670D P Brooks, L C Contino
British Journal of Pharmacology|May 1, 1990
Vasopressin and the pathogenesis of chronic renal failureD P Brooks, H A Solleveld, L C Contino
European Journal of Pharmacology|October 2, 1990
Upregulation of renal endothelin receptors in rats with cyclosporine A-induced nephrotoxicityP Nambi, M Pullen, L C Contino, et al.
British Journal of Pharmacology|December 1, 1991
Increased endothelin excretion in rats with renal failure induced by partial nephrectomyD P Brooks, L C Contino, B Storer, et al.
Pharmacology|May 22, 2001
Parathyroid hormone-1 receptor down-regulation in kidneys from rats with chronic renal failureR M Edwards, L C Contino, M Gellai, et al.
Pharmacology|July 22, 1998
Angiotensin-converting enzyme inhibition alters clusterin mRNA expression in the kidney following renal mass reductionB A Olson, S M Ali, L C Contino, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1995
SB 203220: a novel angiotensin II receptor antagonist and renoprotective agentD P Brooks, L C Contino, B G Short, et al.
Physiological Genomics|November 14, 2000
Gene expression in rats with renal disease treated with the angiotensin II receptor antagonist, eprosartanV Y Wong, N J Laping, L C Contino, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Pharmacology|May 23, 1998
Involvement of nitric oxide synthase in proteinuria associated with chronic renal disease in ratsD P Brooks, L C Contino
Archives of Biochemistry and Biophysics|January 1, 1988
Rat kidney mitochondrial carbonic anhydraseS J Dodgson, L C Contino
European Journal of Pharmacology|December 29, 1995
Prevention of cyclosporine A-induced renal vasoconstriction by the endothelin receptor antagonist SB 209670D P Brooks, L C Contino
British Journal of Pharmacology|May 1, 1990
Vasopressin and the pathogenesis of chronic renal failureD P Brooks, H A Solleveld, L C Contino
European Journal of Pharmacology|October 2, 1990
Upregulation of renal endothelin receptors in rats with cyclosporine A-induced nephrotoxicityP Nambi, M Pullen, L C Contino, et al.
British Journal of Pharmacology|December 1, 1991
Increased endothelin excretion in rats with renal failure induced by partial nephrectomyD P Brooks, L C Contino, B Storer, et al.
Pharmacology|May 22, 2001
Parathyroid hormone-1 receptor down-regulation in kidneys from rats with chronic renal failureR M Edwards, L C Contino, M Gellai, et al.
Pharmacology|July 22, 1998
Angiotensin-converting enzyme inhibition alters clusterin mRNA expression in the kidney following renal mass reductionB A Olson, S M Ali, L C Contino, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1995
SB 203220: a novel angiotensin II receptor antagonist and renoprotective agentD P Brooks, L C Contino, B G Short, et al.
Physiological Genomics|November 14, 2000
Gene expression in rats with renal disease treated with the angiotensin II receptor antagonist, eprosartanV Y Wong, N J Laping, L C Contino, et al.
Pageof 2